Cargando…

Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians

Cost-effectiveness analysis, the most common type of economic evaluation, estimates a new option's additional outcome in relation to its extra costs. This is crucial to study within the clinical setting because funding for new treatments and interventions is often linked to whether there is evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoch, Jeffrey S., Haynes, Sarah C., Hearney, Shannon M., Dewa, Carolyn S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers, Inc. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300047/
https://www.ncbi.nlm.nih.gov/pubmed/35858609
http://dx.doi.org/10.1055/s-0042-1750347
_version_ 1784751119364259840
author Hoch, Jeffrey S.
Haynes, Sarah C.
Hearney, Shannon M.
Dewa, Carolyn S.
author_facet Hoch, Jeffrey S.
Haynes, Sarah C.
Hearney, Shannon M.
Dewa, Carolyn S.
author_sort Hoch, Jeffrey S.
collection PubMed
description Cost-effectiveness analysis, the most common type of economic evaluation, estimates a new option's additional outcome in relation to its extra costs. This is crucial to study within the clinical setting because funding for new treatments and interventions is often linked to whether there is evidence showing they are a good use of resources. This article describes how to analyze a cost-effectiveness dataset using the framework of a net benefit regression. The process of creating estimates and characterizing uncertainty is demonstrated using a hypothetical dataset. The results are explained and illustrated using graphs commonly employed in cost-effectiveness analyses. We conclude with a call to action for researchers to do more person-level cost-effectiveness analysis to produce evidence of the value of new treatments and interventions. Researchers can utilize cost-effectiveness analysis to compare new and existing treatment mechanisms.
format Online
Article
Text
id pubmed-9300047
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Thieme Medical Publishers, Inc.
record_format MEDLINE/PubMed
spelling pubmed-93000472022-07-21 Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians Hoch, Jeffrey S. Haynes, Sarah C. Hearney, Shannon M. Dewa, Carolyn S. Semin Speech Lang Cost-effectiveness analysis, the most common type of economic evaluation, estimates a new option's additional outcome in relation to its extra costs. This is crucial to study within the clinical setting because funding for new treatments and interventions is often linked to whether there is evidence showing they are a good use of resources. This article describes how to analyze a cost-effectiveness dataset using the framework of a net benefit regression. The process of creating estimates and characterizing uncertainty is demonstrated using a hypothetical dataset. The results are explained and illustrated using graphs commonly employed in cost-effectiveness analyses. We conclude with a call to action for researchers to do more person-level cost-effectiveness analysis to produce evidence of the value of new treatments and interventions. Researchers can utilize cost-effectiveness analysis to compare new and existing treatment mechanisms. Thieme Medical Publishers, Inc. 2022-07-20 /pmc/articles/PMC9300047/ /pubmed/35858609 http://dx.doi.org/10.1055/s-0042-1750347 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Hoch, Jeffrey S.
Haynes, Sarah C.
Hearney, Shannon M.
Dewa, Carolyn S.
Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians
title Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians
title_full Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians
title_fullStr Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians
title_full_unstemmed Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians
title_short Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians
title_sort analyzing a cost-effectiveness dataset: a speech and language example for clinicians
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300047/
https://www.ncbi.nlm.nih.gov/pubmed/35858609
http://dx.doi.org/10.1055/s-0042-1750347
work_keys_str_mv AT hochjeffreys analyzingacosteffectivenessdatasetaspeechandlanguageexampleforclinicians
AT haynessarahc analyzingacosteffectivenessdatasetaspeechandlanguageexampleforclinicians
AT hearneyshannonm analyzingacosteffectivenessdatasetaspeechandlanguageexampleforclinicians
AT dewacarolyns analyzingacosteffectivenessdatasetaspeechandlanguageexampleforclinicians